Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Fetal tracheal balloon procedure to help lungs grow in severe congenital diaphragmatic hernia

Official title: Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Right and Left Congenital Diaphragmatic Hernia (CDH)

Run by University of Colorado, Denver · NCT03674372 · Data updated 2026-11-12

This will try a temporary tracheal balloon (FETO) in pregnant women carrying a fetus with severe left or right congenital diaphragmatic hernia to see if it helps the lungs grow and is safe.

More Congenital Diaphragmatic Hernia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment10 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Locations1 site (Aurora, Colorado)
StatusRecruiting
StartedNovember 16, 2018
Main results expectedMarch 2030
Study endsMarch 2030
Registry record updatedJune 10, 2025
Trial IDNCT03674372 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women aged 18 or older with a singleton fetus diagnosed with isolated left or right CDH with liver-up, normal fetal karyotype, and severe pulmonary hypoplasia (L-sided O/E LHR <25% or R-sided O/E LHR <45%) enrolled before 29 weeks 6 days are the intended candidates.

Probably not a fit

Pregnancies with milder CDH, chromosomal abnormalities, multiple gestation, advanced gestational age beyond the enrollment window, or maternal contraindications to fetoscopy are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional protocol places a balloon in the fetal trachea via fetoscopy to block airway egress and stimulate lung growth, with a second procedure to remove the device before birth. Eligibility focuses on singleton pregnancies with isolated left or right CDH, liver-up, normal karyotype, and severe pulmonary hypoplasia defined by O/E LHR thresholds, enrolled before 29 weeks and 6 days gestation. The team monitors the pregnancy while the balloon remains in place and performs planned balloon release and postnatal follow-up including neonatal respiratory support as needed. The goal is to increase lung volume prenatally so newborns have improved lung function and survival after delivery.

Why it matters

Potential benefit: If successful, fetal tracheal occlusion could increase lung growth before birth and improve newborn survival and respiratory outcomes.

How similar studies have gone: Prior case series and multicenter trials of FETO have shown increased fetal lung growth and improved survival for selected severe CDH cases, though outcomes and risks vary across studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women age 18 years and older, who are able to consent
* Singleton pregnancy

Fetal

* Normal Karyotype
* Fetal Diagnosis of Isolated Left or Right CDH with liver up
* Gestation at enrollment prior to 29 wks plus 6 days
* SEVERE pulmonary hypoplasia with Ultra Sound L-sided O/E LHR \< 25% or R-sided O/E LHR \<45%

Exclusion Criteria:

* Pregnant women \<18 years of age.
* Maternal contraindication to fetoscopic surgery or severe maternal medical condition in pregnancy
* Technical limitations precluding fetoscopic surgery
* Rubber latex allergy
* Preterm labor, cervix shortened (\<15 mm at enrollment or within 24 hours of FETO balloon insertion procedure) or uterine anomaly strongly predisposing to preterm labor, placenta previa
* Psychosocial ineligibility, precluding consent
* Inability to remain at FETO site during time period of tracheal occlusion, delivery and postnatal care

Where it's running

  • Children's Hospital Colorado
    Aurora, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.